Nicole Worms

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background.

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background.

Journal: Journal of lipid research

Published: September 23, 2025

Anabolic Effects of Salbutamol Are Lost Upon Immobilization.

Anabolic Effects of Salbutamol Are Lost Upon Immobilization.

Journal: Journal of cachexia, sarcopenia and muscle

Published: January 17, 2025

Translatability of mouse muscle-aging for humans: the role of sex.

Translatability of mouse muscle-aging for humans: the role of sex.

Journal: GeroScience

Published: November 06, 2023

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Journal: Frontiers in cellular neuroscience

Published: July 27, 2023

Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice.

Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice.

Journal: International journal of molecular sciences

Published: April 24, 2023

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.

Journal: Frontiers in cellular neuroscience

Published: April 13, 2023

Caloric Restriction Combined with Immobilization as Translational Model for Sarcopenia Expressing Key-Pathways of Human Pathology.

Caloric Restriction Combined with Immobilization as Translational Model for Sarcopenia Expressing Key-Pathways of Human Pathology.

Journal: Aging and disease

Published: October 05, 2022

Milk fat globule membrane attenuates high fat diet-induced neuropathological changes in obese Ldlr-/-.Leiden mice.

Milk fat globule membrane attenuates high fat diet-induced neuropathological changes in obese Ldlr-/-.Leiden mice.

Journal: International journal of obesity (2005)

Published: July 16, 2021

Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.

Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.

Journal: Metabolism: clinical and experimental

Published: May 19, 2021

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.

Journal: Scientific reports

Published: November 13, 2020

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.

Journal: Cells

Published: June 12, 2020

Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.

Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.

Journal: Journal of lipid research

Published: September 24, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026